Inventor
II, STEPHEN L. GWALTNEY
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes15%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
PatentTitleYear
12,552,7722-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD202612,336,982Compositions and methods of modulating short-chain dehydrogenase activity202511,530,191Compounds and uses thereof for the modulation of hemoglobin202211,236,109Compounds and uses thereof for the modulation of hemoglobin2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to GLOBAL BLOOD THERAPEUTICS INC (2)· patent assignee history
2022–2026Based in US· patent location history
2025Patents assigned to RODEO THERAPEUTICS CORP (1)· patent assignee history
2025Patents assigned to UNIV CASE WESTERN RESERVE (1)· patent assignee history
2026Patents assigned to SPRINGWORKS THERAPEUTICS INC (1)· patent assignee history
2026Patents assigned to UNIV LEUVEN KATH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS INC | 2 | 2022 |
| RODEO THERAPEUTICS CORP | 1 | 2025 |
| SPRINGWORKS THERAPEUTICS INC | 1 | 2026 |
| UNIV CASE WESTERN RESERVE | 1 | 2025 |
| UNIV LEUVEN KATH | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2026 |